Anzeige
Mehr »
Mittwoch, 17.12.2025 - Börsentäglich über 12.000 News
So sehen echte Chancen aus: Starke Phase-1-Ergebnisse, fallender Kurs
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTRX | ISIN: US92854B1098 | Ticker-Symbol: U5P
Tradegate
16.12.25 | 12:45
1,170 Euro
+0,86 % +0,010
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVANI MEDICAL INC Chart 1 Jahr
5-Tage-Chart
VIVANI MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,1801,22016.12.
1,1801,23016.12.

Aktuelle News zur VIVANI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Vivani Medical GAAP EPS of -$0.11 in-line1
VIVANI MEDICAL Aktie jetzt für 0€ handeln
13.11.Vivani Medical, Inc.: Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results160Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase...
► Artikel lesen
13.11.Vivani Medical, Inc. - 10-Q, Quarterly Report-
13.11.Vivani Medical, Inc. - 8-K, Current Report-
10.11.VIVANI stellt neue Bio-Schololade aus der ganzen Kakaofrucht vor2
28.10.Vivani Medical, Inc. Announces Closing of Common Stock Offering4
28.10.Vivani Medical, Inc. - 8-K, Current Report-
27.10.Vivani Medical prices $16M offering at $1.62 per share3
27.10.Vivani Medical prices $15.7 million stock offering at $1.62 per share1
27.10.Vivani Medical, Inc. Announces Pricing of Common Stock Offering1
03.10.Vivani delays Cortigent spin-off record date due to government shutdown2
03.10.Vivani Medical, Inc. - 8-K, Current Report1
03.10.Vivani Medical, Inc.: Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off163ALAMEDA, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...
► Artikel lesen
17.09.Vivani sets date for neuromod spin-off as focus turns to drug delivery implant2
17.09.Vivani Medical, Inc. - 8-K, Current Report2
17.09.Vivani Medical, Inc.: Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders233Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision...
► Artikel lesen
05.09.Vivani Medical stock holds Buy rating at H.C. Wainwright on NPM-139 plans1
04.09.Vivani Medical, Inc. - 8-K, Current Report1
04.09.Gewichtsmanagement: Vivani plant Phase-1-Studie für Semaglutid-Implantat-
04.09.Vivani plans phase 1 trial of semaglutide implant for weight management2
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1